[Form 4] GoodRx Holdings, Inc. Insider Trading Activity
GoodRx Holdings (GDRX): insider filing shows share class conversion and small sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GoodRx Holdings (GDRX): insider filing shows share class conversion and small sales. On 10/14/2025, affiliated Spectrum funds converted Class B Common Stock into 8,881,362 Class A shares on a one-for-one basis, then Spectrum Equity VII, L.P. made a pro rata distribution of 8,881,362 Class A shares to partners for no consideration. On 10/15/2025, Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund sold 15,202 and 8,569 Class A shares, respectively, at a weighted average price of $4.0008. After these transactions, each listed fund reported 0 shares beneficially owned.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 15,202 | $4.0008 | $61K |
| Sale | Class A Common Stock | 8,569 | $4.0008 | $34K |
| Conversion | Class B Common Stock | 8,881,362 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 15,202 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 8,569 | $0.00 | $0.00 |
| Conversion | Class A Common Stock | 8,881,362 | $0.00 | $0.00 |
| Conversion | Class A Common Stock | 15,202 | $0.00 | $0.00 |
| Conversion | Class A Common Stock | 8,569 | $0.00 | $0.00 |
| Other | Class A Common Stock | 8,881,362 | $0.00 | $0.00 |
Footnotes (4)
- F1. Represents the conversion of the Issuer's Class B Common Stock ("Class B Shares") into shares of the Issuer's Class A Common Stock (the "Class A Shares") on a one-for-one basis.
- F2. The general partner of Spectrum Equity VII, L.P. ("SE VII") is Spectrum Equity Associates VII, L.P. ("Spectrum Equity Associates"). The general partner of each of Spectrum VII Investment Managers' Fund, L.P. ("Spectrum VII Investment Managers' Fund"), Spectrum VII Co-Investment Fund L.P. ("Spectrum VII Co-Investment Fund"), and Spectrum Equity Associates is SEA VII Management, LLC ("Management LLC"). Brion B. Applegate, Christopher T. Mitchell, Victor E. Parker, Jr., Benjamin C. Spero, Ronan Cunningham, Stephen M. LeSieur, Brian Regan and Michael W. Farrell may be deemed to share voting and dispositive power over the securities held by SE VII, Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund. Each of these individuals disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest, if any.
- F3. Spectrum Equity VII, L.P. made a pro rata distribution of 8,881,362 shares of Class A Shares to its general partner and limited partners for no consideration on October 14, 2025.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.000 to $4.005 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.